跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
沛卓 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Doravirine Tablets
Approved
化学药品
Doravirine Tablets
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Jul 21, 2025
Approval ID
8883nd48YVC
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
8883nd48YVC
Approval Number
国药准字HJ20200050
Generic Name
多拉韦林片
Generic Name En
Doravirine Tablets
Trade Name
沛卓
Brand Name
沛卓
Drug Type
化学药品
Dosage Form
片剂
Strength
100mg
Reg Date
2025-07-21
Expired Date
2030-07-20
Company Name
Merck Sharp & Dohme BV
Production Company Name
MSD International GmbH
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/msd-international-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 21, 2025
Approval ID
8883nd48YVC
Type
化学药品
Back to NMPA Approvals